The International Neuromodulation SocietyThe Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of NeuromodulationThe International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field. Donate TodayThe INS Peer-Reviewed JournalThe INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.
The Neuromodulation Podcast has been developed for our membership to dive into the forefront of today's emerging neuromodulation techniques, insights, and ethical and clinical applications. Join the multidisciplinary collaboration of medical care providers, scientists, and engineers who are part of the global conversation that's shaping the future of healthcare. Subscribe now wherever you get your podcasts. What is Neuromodulation?Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application. Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:
Breaking NewsNoninvasive Vagus Nerve Stimulation May Boost Post-Exercise Recovery April 2, 2026 - A randomized controlled trial published found that auricular transcutaneous vagus nerve stimulation (taVNS) applied after exercise improved markers of autonomic recovery in physically inactive young adults. Participants receiving stimulation showed greater reductions in blood pressure, lactate levels, and perceived fatigue compared to exercise alone, along with enhanced parasympathetic activity. The findings suggest that taVNS could support faster recovery following physical exertion. (Source: Scientific Reports) Noninvasive Brain Stimulation Targets Deep Memory Circuits April 2, 2026 - Researchers at the University of Iowa Health Care demonstrated that noninvasive brain stimulation applied to the scalp can modulate activity in the deep hippocampus by targeting connected surface brain regions. The study, published in Nature Communications, showed that personalized stimulation based on each patient’s brain connectivity produced significantly stronger effects, with findings validated in both neurosurgical patients and healthy participants. (Source: Neuroscience News) Implanted Brain Device Detects Walking in Parkinson’s Patients at Home March 9, 2026 - Researchers at the University of California, San Francisco demonstrated that a fully implanted brain device can detect when people with Parkinson’s disease are walking during daily life by recording neural activity from movement-related brain regions. In a small feasibility study, machine learning analysis of more than 80 hours of at-home data identified walking with over 95% accuracy, validated by wearable sensors. The findings, published in Science Advances, suggest that such neural signals could support future adaptive neuromodulation therapies that adjust stimulation based on a patient’s activity. (Source: Parkinson’s News Today) Deep Brain Stimulation Provides Relief for Patient with Tourette Syndrome Patient March 7, 2026 - A woman with severe Tourette syndrome experienced substantial symptom improvement after undergoing deep brain stimulation. After the procedure and several months of recovery and device adjustment, her symptoms decreased significantly, allowing her to return to work, resume daily activities, and continue planning her future. The case highlights the potential of neuromodulation as a treatment option for patients with severe, treatment-resistant Tourette syndrome. (Source: MSN) Review Examines Clinical Trial Design Challenges for Transcutaneous Spinal Cord Stimulation March 6, 2026 - A methodological review analyzes challenges in designing rigorous clinical trials for transcutaneous spinal cord stimulation in chronic spinal cord injury, particularly difficulties in implementing effective sham controls. The authors highlight technical, ethical, and practical constraints, including participant burden and issues amplified by long study protocols and discuss alternative approaches such as sequential self-controlled, biomarker-guided, and adaptive trial designs. (Source: Nature) To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive. Continue Reading News Briefs |
